marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-30-2024
Blueprint Medicines Corporation Financial Statements 2011-2024 | BPMC
Annual Financial Statements Blueprint Medicines Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
5.31 B | 2.66 B | 6.27 B | 6.12 B | 3.07 B | 3.11 B | 3.06 B | 913 M | 287 M | - | - | - | - |
Shares |
60.6 M | 59.6 M | 58.5 M | 54.5 M | 47.8 M | 43.9 M | 37.8 M | 27.5 M | 18.2 M | - | - | - | - |
Historical Prices |
87.6 | 44.5 | 107 | 112 | 80.1 | 53.9 | 75.4 | 28.1 | 26.3 | - | - | - | - |
Net Income |
-507 M | -558 M | -644 M | 314 M | -348 M | -237 M | -148 M | -72.5 M | -52.8 M | -40.3 M | -20.9 M | - | - |
Revenue |
249 M | 204 M | 180 M | 794 M | 66.5 M | 44.5 M | 21.4 M | 27.8 M | 11.4 M | - | - | - | - |
Cost of Revenue |
8.54 M | 17.8 M | 17.9 M | 425 K | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
-946 K | 2 M | -1.49 M | -366 K | -100 K | -180 K | -76 K | 551 K | -429 K | -98 K | 226 K | - | - |
EBITDA |
11.7 M | 11.7 M | 6.48 M | 6.56 M | -356 M | -243 M | -150 M | -71 M | -50.7 M | -39.2 M | -20.3 M | - | - |
Operating Expenses |
- | - | - | - | 428 M | 292 M | 173 M | 100 M | 63 M | - | - | - | - |
General and Administrative Expenses |
295 M | 237 M | 195 M | 158 M | 96.4 M | 47.9 M | 28 M | 19.2 M | 14.5 M | 7.89 M | 5.07 M | - | - |
All numbers in USD currency
Quarterly Income Statement Blueprint Medicines Corporation
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
63.4 M | 62.9 M | 61.6 M | 61.1 M | 60.7 M | 60.5 M | 60.1 M | 60 M | 59.8 M | 59.6 M | 59.3 M | 59.1 M | 58.6 M | 58.4 M | 58 M | 57.8 M | 55.2 M | 54.2 M | 52.7 M | 49.3 M | 48.9 M | 48.8 M | 44.1 M | 44 M | 43.9 M | 43.9 M | 43.7 M | 43.6 M | 39.1 M | 38.8 M | 33.2 M | 33.1 M | 27.3 M | 27.2 M | 27.1 M | 27.1 M | 26.8 M | 17.1 M | 1.68 M | 1.63 M | 1.45 M | 1.37 M | 1.28 M | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-56.3 M | -50 M | 89.1 M | - | -134 M | -133 M | -130 M | - | -133 M | -160 M | -106 M | - | -117 M | -108 M | -99.7 M | - | 634 M | -123 M | -111 M | -66.3 M | -94.3 M | -99.7 M | -87.4 M | -80.3 M | -72.7 M | -27 M | -56.5 M | -49 M | -37.7 M | -33.4 M | -28 M | -21.3 M | -16.8 M | -18.9 M | -15.5 M | -15.6 M | -12.6 M | -13 M | -11.6 M | -14.5 M | -10.5 M | -8.29 M | -7.03 M | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
128 M | 138 M | 96.1 M | - | 56.6 M | 57.6 M | 63.3 M | - | 66 M | 36.5 M | 62.7 M | - | 24.2 M | 27.3 M | 21.6 M | - | 745 M | 8.34 M | 6.17 M | 51.5 M | 9.14 M | 5.11 M | 730 K | 1.03 M | 1.1 M | 41.4 M | 954 K | 1.63 M | 8.07 M | 5.89 M | 5.84 M | 7.69 M | 6.16 M | 7.06 M | 6.86 M | 4.64 M | 3.43 M | 2.69 M | 652 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
1.93 M | 7.59 M | 3.19 M | - | 2.78 M | 2.32 M | 3.18 M | - | 3 M | 4.89 M | 5.08 M | - | 3.79 M | 6.49 M | 102 K | - | 146 K | 127 K | 24 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
587 K | -1 K | 376 K | - | -728 K | -626 K | 986 K | - | 396 K | 632 K | -453 K | - | -522 K | -373 K | -214 K | - | -192 K | -23 K | -201 K | - | -72 K | -42 K | -44 K | - | 2.8 M | 2.44 M | 2.39 M | - | 954 K | 861 K | 425 K | - | 158 K | 131 K | 61 K | - | 6 K | -405 K | -37 K | - | -94 K | 1 K | 18 K | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | 4.81 M | - | - | - | 3.68 M | - | 4.72 M | - | 1.63 M | - | 4.82 M | 1.6 M | 1.61 M | - | 4.89 M | 3.24 M | 1.57 M | - | 3.68 M | 2.39 M | 1.18 M | - | 3.08 M | 1.91 M | 780 K | - | 1.19 M | 791 K | 398 K | - | 1.19 M | 782 K | 386 K | - | 615 K | 411 K | 209 K | - | 416 K | 273 K | 134 K | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 121 M | 107 M | 109 M | 90.8 M | 84.2 M | 76.6 M | 70.9 M | 59.9 M | 51.7 M | 46.7 M | 40.1 M | 34.2 M | 29.1 M | 23 M | 26 M | 22.3 M | 20.1 M | 15.9 M | 15.1 M | 12 M | 14.3 M | 10.3 M | 8.2 M | 6.95 M | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
89.9 M | 89.3 M | 83.6 M | - | 70.7 M | 71.9 M | 71 M | - | 57.6 M | 58.7 M | 57.1 M | - | 49.8 M | 49.3 M | 42 M | - | 37.4 M | 42.2 M | 35.7 M | - | 25.6 M | 21.9 M | 16.6 M | - | 12 M | 12.3 M | 9.91 M | - | 7.38 M | 6.83 M | 5.68 M | - | 4.89 M | 4.69 M | 4.65 M | - | 4.22 M | 3.84 M | 2.77 M | - | 1.92 M | 1.44 M | 1.57 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency